FrontNewsTop StoriesWorld

Global Developments On Top Potential COVID-19 Vaccines

The outbreak of the Coronavirus pandemic has ravaged the world with infections and fatalities spreading unevenly at alarming rates across the country.  The pandemic has scattered businesses, decimated lives and disrupted the global economy.
While the world has joined forces, global companies are working round-the-clock with medical researchers  scrambling only to lay hands on their first breakthrough, in inventing a vaccine to combat COVID-19.

Here are the 4 potential coronavirus vaccines under development: 

​Italy claims to develop first COVID-19 vaccine: 
Italy the worst-hit country by the Coronavirus outbreak has revived the hopes of the world as a team of Italian researchers at Lazzaro Spallanzani National Institute for Infectious Diseases in Rome announced to have discovered the world’s first vaccine that can neutralise coronavirus. The vaccine made by Italy has successfully generated antibodies in mice that work on human cells and is believed to be one of the most advanced stages of testing of a potential vaccine in the country as it likely could work on the SARS-CoV-2 in the human cells.
With claims that vaccine candidates could likely adapt to COVID-19 evolutions, Italy’s efforts seems to have hit a shot in battle with COVID-19.

Israel’s terrific breakthrough:
In an official statement, Israeli Defence Minister Naftali Bennett announced of developing a monoclonal neutralising antibody at Israel’s Institute for Biological Research (IIBR) 
Calling it a significant breakthrough, Bennett claimed that Israel invented a key COVID antibody that ‘attacks and neutralises’ the virus in the carrier’s body. Though Israel has achieved a terrific breakthrough it however still is unclear if the vaccine has been tested on humans.

The Oxford vaccine against Coronavirus:
The University of Oxford began the Phase-1 human clinical trial of its vaccine developed by the Jenner Institute and Oxford Vaccine Group. The potential vaccine -ChAdOx1 nCoV-19- being a recombinant adenovirus vaccine aims to prevent COVID-19 infection rising from SARS-CoV-2. The vaccine developed was injected on two volunteers to test & gain profound results. Oxford’s trials and efforts to accelerate the globalisation of a vaccine may soon yield the fruit the world awaits.

The Convalescent Plasma Therapy:
This can possibly emerge as a promising treatment for COVID-19 infection. The Plasma Therapy treatment involves taking antibodies from the blood of a person, recovered from COVID-19 and transfusing those antibodies into an active COVID-19 patient. The antibody then creates passive immunization in the sick person to combat the virus and recover. Several states in India have adopted the plasma therapy as reports reveal patients to have neared recovery. With Plasma Therapy holding potential miracles the Union Health Ministry has warned that the treatment could possibly deviate itself to life-threatening transfusion complications as being under experiment stage it is yet not defined to be the ultimate weapon in fight against Coronavirus.

While India continues to battle the fatal COVID-19, cases keep sprawling in the country breaching the 50,000 mark.
Reports suggest that more than 30 vaccines are underway in different stages of development while few are set to go for clinical trials.
India renowned as the ‘vaccine manufacturing powerhouse’ producing 60 per cent of the world’s vaccines aspires to soon unleash a remarkable breakthrough under progress at the world’s largest vaccine maker, The Serum Institute of India. If trials are successful India may soon have its breakthrough vaccine to defeat COVID-19.



NMTV was launched in the year 1999, and is Maharashtra only accredited 24-hour, 7-day-a-week local cable news station of Navi Mumbai airing news bulletins and programs in English, Hindi and Marathi. NMTV represents the state-of-the-art in local television news coverage, delivering on a commitment of responsible and community-oriented journalism on an around-the-clock basis.

Related Articles

Back to top button